NASDAQ
SMFR

Sema4 Holdings Corp

Healthcare Providers & Services
Healthcare

Prices are adjusted according to historical splits.

Sema4 Holdings Corp Stock Price

Vitals

Today's Low:
$0.3419
Today's High:
$0.3901
Open Price:
$0.3901
52W Low:
$0.22
52W High:
$1.07
Prev. Close:
$0.3901
Volume:
7403388

Company Statistics

Market Cap.:
$120.14 million
Book Value:
1.472
Revenue TTM:
$231.14 million
Operating Margin TTM:
-190.2%
Gross Profit TTM:
$-16602000
Profit Margin:
-121.31%
Return on Assets TTM:
-38.37%
Return on Equity TTM:
-58.87%

Company Profile

Sema4 Holdings Corp had its IPO on 2020-11-04 under the ticker symbol SMFR.

The company operates in the Healthcare sector and Healthcare Providers & Services industry. Sema4 Holdings Corp has a staff strength of 1,200 employees.

Stock update

Shares of Sema4 Holdings Corp opened at $0.39 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $0.34 - $0.39, and closed at $0.34.

This is a -12.05% slip from the previous day's closing price.

A total volume of 7,403,388 shares were traded at the close of the day’s session.

In the last one week, shares of Sema4 Holdings Corp have slipped by -24.58%.

Sema4 Holdings Corp's Key Ratios

Sema4 Holdings Corp has a market cap of $120.14 million, indicating a price to book ratio of 0.205 and a price to sales ratio of 0.4691.

In the last 12-months Sema4 Holdings Corp’s revenue was $231.14 million with a gross profit of $-16602000 and an EBITDA of $-415177984. The EBITDA ratio measures Sema4 Holdings Corp's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Sema4 Holdings Corp’s operating margin was -190.2% while its return on assets stood at -38.37% with a return of equity of -58.87%.

In Q3, Sema4 Holdings Corp’s quarterly earnings growth was a positive 0% while revenue growth was a positive 92.8%.

Sema4 Holdings Corp’s PE and PEG Ratio

Forward PE
0
Trailing PE
1.553
PEG

Its diluted EPS in the last 12-months stands at $0.2 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Sema4 Holdings Corp’s profitability.

Sema4 Holdings Corp stock is trading at a EV to sales ratio of 0.0073 and a EV to EBITDA ratio of -0.0057. Its price to sales ratio in the trailing 12-months stood at 0.4691.

Sema4 Holdings Corp stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets
$490.94 million
Total Liabilities
$144.30 million
Operating Cash Flow
$-2838000.00
Capital Expenditure
$2.17 million
Dividend Payout Ratio
0%

Sema4 Holdings Corp ended 2024 with $490.94 million in total assets and $0 in total liabilities. Its intangible assets were valued at $490.94 million while shareholder equity stood at $253.71 million.

Sema4 Holdings Corp ended 2024 with $2.66 million in deferred long-term liabilities, $144.30 million in other current liabilities, 38000.00 in common stock, $-1124421000.00 in retained earnings and $0 in goodwill. Its cash balance stood at $123.93 million and cash and short-term investments were $123.93 million. The company’s total short-term debt was $6,121,000 while long-term debt stood at $6.25 million.

Sema4 Holdings Corp’s total current assets stands at $212.62 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $49.83 million compared to accounts payable of $88.47 million and inventory worth $13.67 million.

In 2024, Sema4 Holdings Corp's operating cash flow was $-2838000.00 while its capital expenditure stood at $2.17 million.

Comparatively, Sema4 Holdings Corp paid $0 in dividends in 2024.

Other key metrics

Current Trading Price
$0.34
52-Week High
$1.07
52-Week Low
$0.22
Analyst Target Price
$1.75

Sema4 Holdings Corp stock is currently trading at $0.34 per share. It touched a 52-week high of $1.07 and a 52-week low of $1.07. Analysts tracking the stock have a 12-month average target price of $1.75.

Its 50-day moving average was $0.41 and 200-day moving average was $0.97 The short ratio stood at 1.73 indicating a short percent outstanding of 0%.

Around 4867.7% of the company’s stock are held by insiders while 3929.4% are held by institutions.

Frequently Asked Questions About Sema4 Holdings Corp

The stock symbol (also called stock or share ticker) of Sema4 Holdings Corp is SMFR

The IPO of Sema4 Holdings Corp took place on 2020-11-04

Similar Industry Stocks (Healthcare Providers & Services)

Last Price
Chg
Chg%
$337.45
1
+0.3%
$7.4
-0.03
-0.4%
$227.9
-10.14
-4.26%
$1173
16.6
+1.44%
$0.34
0.02
+6.22%
Sohm Inc. (SHMN)
$0
0
+10%
$0.11
-0.01
-8.33%
$0.22
-0.03
-10.63%
$1445.35
-58.9
-3.92%
$71.85
-5.23
-6.79%

Most Active

Last Price
Chg
Chg%
Amyris Inc (AMRS)
$0.14
0.07
+100%
$0.12
0.04
+45.29%
$0.96
0.05
+5.4%
$1.34
-0.35
-20.71%
Humbl Inc (HMBL)
$0
0
0%

Top Gainers

Last Price
Chg
Chg%
$0
0
+172200%
$0
0
+51200%
$283
280.03
+9428.62%
$11.2
10.57
+1667.68%
Latch Inc (LTCHW)
$0.01
-0.03
+1550%

Top Losers

Last Price
Chg
Chg%
$0.19
-123.15
-99.85%
$0
-0.11
-99.55%
$0
-0
-97.96%
$0
-0.01
-93.94%
$0.01
-0.06
-92.24%

About

Sema4 Holdings Corp., doing business as Sema4, operates as a health information company that enhances diagnosis, treatment, and prevention of disease through data. The company provides Centrellis, an AI-driven health intelligence platform that delivers comprehensive insights to biopharma to accelerate the drug discovery, development, and commercialization life-cycle, as well as analytics for actionable insights, pre-clinical and clinical trial support, and advanced sequencing services. It also offers Sema4 Signal that enables and advances precision oncology care, from prevention to treatment to remission; and testing for carrier screening, noninvasive prenatal testing, and newborn screening, as well as hereditary cancer testing. In addition, the company provides COVID-19 testing solutions. Sema4 Holdings Corp. was incorporated in 2020 and is headquartered in Stamford, Connecticut.

Address

North Tower, Stamford, CT, United States, 06902